Klinikum der Universität München AÖR

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Bronchiectasis2 trials
• Colorectal cancer1 trial
• Sarcoma1 trial

Phase

• Phase 32 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Recruiting2 trials
• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Boehringer Ingelheim3 trials
• Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1 trial

Running trials

• Not yet recruiting

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases

  NCT06856837· Phase 2· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Source

  Contact: Sabrina Opatz, Dr.

• Recruiting

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bronchiectasis2 recruiting
• Colorectal cancer1 recruiting

Closed trials

• Completed

  Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma

  NCT05218499· Phase 2/3· Boehringer Ingelheim· Source